BRPI0812942A2 - Composto, composição farmacêutica e uso de um composto - Google Patents
Composto, composição farmacêutica e uso de um compostoInfo
- Publication number
- BRPI0812942A2 BRPI0812942A2 BRPI0812942-8A2A BRPI0812942A BRPI0812942A2 BR PI0812942 A2 BRPI0812942 A2 BR PI0812942A2 BR PI0812942 A BRPI0812942 A BR PI0812942A BR PI0812942 A2 BRPI0812942 A2 BR PI0812942A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2007052301 | 2007-06-15 | ||
| PCT/IB2008/052333 WO2008152603A1 (en) | 2007-06-15 | 2008-06-13 | 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0812942A2 true BRPI0812942A2 (pt) | 2014-12-16 |
| BRPI0812942A8 BRPI0812942A8 (pt) | 2018-05-02 |
| BRPI0812942B1 BRPI0812942B1 (pt) | 2018-11-21 |
Family
ID=39772866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0812942A BRPI0812942B1 (pt) | 2007-06-15 | 2008-06-13 | composto derivado de 3-amino-6 - (1-amino-etil) - tetra-hidropirano, composição farmacêutica e uso de referido composto. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8193179B2 (pt) |
| EP (1) | EP2167494B1 (pt) |
| JP (1) | JP5274553B2 (pt) |
| KR (1) | KR101538814B1 (pt) |
| CN (1) | CN101711243B (pt) |
| AR (1) | AR067008A1 (pt) |
| AT (1) | ATE520687T1 (pt) |
| AU (1) | AU2008263397B2 (pt) |
| BR (1) | BRPI0812942B1 (pt) |
| CA (1) | CA2689102C (pt) |
| ES (1) | ES2370123T3 (pt) |
| MX (1) | MX2009013254A (pt) |
| PL (1) | PL2167494T3 (pt) |
| TW (1) | TWI414290B (pt) |
| WO (1) | WO2008152603A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2411930T3 (es) | 2008-02-20 | 2013-07-09 | Actelion Pharmaceuticals Ltd. | Compuestos antibióticos azatricíclicos |
| WO2009147616A1 (en) * | 2008-06-03 | 2009-12-10 | Actelion Pharmaceuticals Ltd | [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials |
| KR101294962B1 (ko) | 2008-10-07 | 2013-08-12 | 액테리온 파마슈티칼 리미티드 | 트리사이클 옥사졸리디논 항생제 화합물 |
| CN102232078B (zh) * | 2008-12-12 | 2014-07-16 | 埃科特莱茵药品有限公司 | 5-氨基-2-(1-羟基-乙基)-四氢吡喃衍生物 |
| WO2012164498A1 (en) | 2011-05-31 | 2012-12-06 | Actelion Pharmaceuticals Ltd | New synthetic intermediates for manufacturing antibiotics |
| AU2012275499A1 (en) * | 2011-06-27 | 2013-12-19 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
| CN106083787B (zh) * | 2016-06-21 | 2018-05-04 | 济南川成医药科技开发有限公司 | 一种4-(2-氨乙基)四氢吡喃的合成方法 |
| WO2018026877A1 (en) | 2016-08-05 | 2018-02-08 | Calitor Sciences, Llc | Process for preparing substituted quinolin-4-ol compounds |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| CR20200054A (es) | 2017-08-09 | 2020-03-21 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
| HUE062446T2 (hu) | 2017-09-01 | 2023-11-28 | Denali Therapeutics Inc | Vegyületek, készítmények és eljárások |
| EP3923935A4 (en) | 2019-02-13 | 2022-10-26 | Denali Therapeutics Inc. | COMPOUNDS, COMPOSITIONS AND METHODS |
| MA54959A (fr) | 2019-02-13 | 2021-12-22 | Denali Therapeutics Inc | Composés, compositions et procédés |
| GB201904469D0 (en) | 2019-03-29 | 2019-05-15 | Givaudan Sa | Cosmetic composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
| EP1551829B1 (de) * | 2002-10-10 | 2010-04-07 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Neue verbindungen mit antibakterieller aktivität |
| JP2008507543A (ja) * | 2004-07-22 | 2008-03-13 | グラクソ グループ リミテッド | 抗細菌剤 |
| DE102004041163A1 (de) * | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| JP4887297B2 (ja) * | 2004-09-24 | 2012-02-29 | アクテリオン ファーマシューティカルズ リミテッド | 新規二環式抗生物質 |
| WO2006046552A1 (ja) | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
| WO2006125974A1 (en) * | 2005-05-24 | 2006-11-30 | Astrazeneca Ab | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| CN101374831B (zh) * | 2006-01-26 | 2011-04-27 | 埃科特莱茵药品有限公司 | 四氢吡喃抗生素 |
| EP1996579A2 (en) * | 2006-03-10 | 2008-12-03 | Actelion Pharmaceuticals Ltd. | Antibiotic compounds |
-
2008
- 2008-06-13 CN CN2008800187896A patent/CN101711243B/zh not_active Expired - Fee Related
- 2008-06-13 TW TW097122296A patent/TWI414290B/zh not_active IP Right Cessation
- 2008-06-13 AR ARP080102542A patent/AR067008A1/es unknown
- 2008-06-13 ES ES08763320T patent/ES2370123T3/es active Active
- 2008-06-13 PL PL08763320T patent/PL2167494T3/pl unknown
- 2008-06-13 WO PCT/IB2008/052333 patent/WO2008152603A1/en not_active Ceased
- 2008-06-13 AT AT08763320T patent/ATE520687T1/de active
- 2008-06-13 MX MX2009013254A patent/MX2009013254A/es active IP Right Grant
- 2008-06-13 CA CA2689102A patent/CA2689102C/en not_active Expired - Fee Related
- 2008-06-13 AU AU2008263397A patent/AU2008263397B2/en not_active Ceased
- 2008-06-13 JP JP2010511771A patent/JP5274553B2/ja not_active Expired - Fee Related
- 2008-06-13 US US12/664,828 patent/US8193179B2/en not_active Expired - Fee Related
- 2008-06-13 EP EP08763320A patent/EP2167494B1/en not_active Not-in-force
- 2008-06-13 KR KR1020107000842A patent/KR101538814B1/ko not_active Expired - Fee Related
- 2008-06-13 BR BRPI0812942A patent/BRPI0812942B1/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US8193179B2 (en) | 2012-06-05 |
| WO2008152603A1 (en) | 2008-12-18 |
| TW200906416A (en) | 2009-02-16 |
| CA2689102C (en) | 2016-07-26 |
| EP2167494B1 (en) | 2011-08-17 |
| KR20100023031A (ko) | 2010-03-03 |
| AU2008263397A1 (en) | 2008-12-18 |
| CN101711243A (zh) | 2010-05-19 |
| RU2010101003A (ru) | 2011-07-20 |
| CA2689102A1 (en) | 2008-12-18 |
| AU2008263397B2 (en) | 2013-12-05 |
| EP2167494A1 (en) | 2010-03-31 |
| AR067008A1 (es) | 2009-09-30 |
| ES2370123T3 (es) | 2011-12-12 |
| PL2167494T3 (pl) | 2012-01-31 |
| BRPI0812942B1 (pt) | 2018-11-21 |
| CN101711243B (zh) | 2013-01-09 |
| US20100179135A1 (en) | 2010-07-15 |
| BRPI0812942A8 (pt) | 2018-05-02 |
| KR101538814B1 (ko) | 2015-07-22 |
| ATE520687T1 (de) | 2011-09-15 |
| TWI414290B (zh) | 2013-11-11 |
| JP2010529983A (ja) | 2010-09-02 |
| JP5274553B2 (ja) | 2013-08-28 |
| MX2009013254A (es) | 2010-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
| BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
| BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
| BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
| BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
| BRPI0819696A2 (pt) | Compostos de derivados de 2-fenil-pirimidina, composição farmacêutica e uso de um composto | |
| BRPI0609802A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
| BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
| BRPI0716698A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
| BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0917001A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
| BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
| BRPI0915473A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0915134A2 (pt) | composto, e, uso de um composto | |
| BRPI0919165A2 (pt) | composição farmacêutica,e, uso de um composto | |
| BRPI0918517A2 (pt) | composto, composição farmacêutica, e, uso de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
| B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
| B25C | Requirement related to requested transfer of rights |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 12A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |